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Objectives: To aim to determine the status and epidemiological aspects of malaria in
Iran in favour of gaining a better understanding of the national control of malaria.
Methods: This epidemiological study examined the status of malaria from 2011 to 2014
in Iran. Data were collected from the Ministry of Health's protocol for controlling and
eliminating malaria, which is currently in use. This malaria information reporting system
is automated in all Iranian provinces and cities, and all information is submitted online to
the center for communicable disease control in the Ministry of Health. Information about
malaria is available for researchers to evaluate.
Results: The incidence rates decreased from 2011 to 2014. There were 4.76, 2.12, 1.80,
and 1.59 per 100000 people, respectively from 2011 to 2014. During the four-year period
(2011–2014), the highest numbers of cases occurred in those aged 16–25 years, by age,
and in men, by sex. Most of the cases were workers and located in rural areas. An average
52.58% of cases were Iranian. The highest incidence rates from 2011 to 2014 were
located in Sistan and Baluchestan province. There were 89.94, 43.9, 38.3, and 30.66 per
100000 people. The highest numbers of malaria cases were recorded in the cities Sarbaz,
Nickshahr, and Chabahar in Sistan and Baluchestan province and Bandar Abbas, Bandar
Jask, and Bandar Lengeh in Hormozgan province. During the four-year period, 57.05% of
cases were caused by imported factors. The majority of cases were related to the
trophozoite lifecycle of parasites. Regarding surveillance, there was inactive care in the
majority of cases. Vivax malaria was the most prevalent.
Conclusions: Despite the recently declining trend in reported cases, the expansion of local
transmission, especially in areas with cross-border travel, is very worrying. Improved
malaria control interventions can be effective for elimination of malaria in Iran; these can
include programs to control border travel and focused interventions for high incidence
areas and high-risk groups such as rural residents, men, workers, and people <35 years old.1. Introduction
Malaria is a global tropical and semi-tropical parasitic disease
that is considered a major public health problem [1]. Malaria is a
vector-borne disease caused by protozoan parasites that belong
to the genus Plasmodium. The parasites are transmitted fromperson to person by infected female anopheles mosquitoes [2].
According to the 2013 World Malaria Report by the World
Health Organization (WHO), there were 207 million cases of
malaria worldwide (uncertainty interval, 135–287 million) and
627000 deaths caused by malaria in 2012 [3]. Of the estimated
3.4 billion people that are at risk of malaria, 1.2 billion are at
high risk. In high-risk areas, more than one malaria case oc-
curs per 1000 population [4].
This disease remains an important cause of mortality and
morbidity in many parts of the world, and it could have adverse
health and socioeconomic impacts on the population [5]. The
total international and domestic funding committed to malaria
control was estimated to be US $2.5 billion in 2012, which is
substantially less than the amount that will be needed to reachnder the CC BY-NC-ND license (http://
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million people and is located in West Asia. It covers an area
of approximately 1.648 million km2, of which mountainous
regions and arid deserts comprise 50% and 25%, respectively [7].
The ﬁrst reports of malaria in Iran date back to 1921, when
cases were found along the northern borders with Azerbaijan
and the Caspian Sea [8]. In 1924, more than one-third of Iran's 13
million people had contracted malaria, and it was considered a
deterrent to the economic development of the country [9,10].
Now, after more than 50 years of control interventions against
malaria in Iran starting in 1956, malaria is still considered an
acute health concern, particularly in the south and southeast of
Iran [1]. In the Eastern Mediterranean Region, the Islamic
Republic of Iran and Saudi Arabia are in the elimination
phase. The number of indigenous cases decreased from 1710
in 2011 to 787 in 2012 (consisting of 756 indigenous, 12
introduced, and 19 suspected relapsing cases) [11]. Therefore,
malaria is still prevalent in many areas [1,12].
The implementation of a regional strategic plan for controlling
malaria is one of the most important reasons for the pre-
elimination stage of malaria in Iran. WHO recommendations,
including preventing the resettlement of pollution in malaria-free
zones and eliminating the disease in areas where malaria trans-
mission, are highly limited. Therefore, elimination of the disease
and prevention of the return of malaria (re-introduction) in Iran,
which is an endemic area, are of high importance. The elimination
of the disease and prevention of the return of malaria (re-intro-
duction) in a country where the disease is endemic is optimal.
Therefore, three operational-technical approaches and four
backup strategies to eliminate malaria have been proposed. The
major strategies include: (1) Improving access to prompt and
effective treatment of malaria; (2) Improving access to preventive
services by strengthening integrated vector management (IVM);
(3) Strengthening the disease surveillance system with an
emphasis on appropriate and timely responses. And the backup
strategies include: (1) Strengthening and developing a monitoring
and evaluation system of interventions for malaria elimination;
(2) Conducting applied research; (3) Using the capacity of all
stakeholders for malaria elimination; (4) Building human capital
capacity and mobilizing resources for malaria elimination [13].
Although previous efforts have reduced the disease burden in
various areas, the malaria elimination program has faced several
challenges because Iran borders malaria-prone countries. If
malaria is not eliminated, economic development will beTable 1
Current malaria surveillance in Iran, including passive and active case ﬁndin
Passive surveillance Routine
Target group
(for detection
of blood smear)
People with fever,
recent malaria cases
(for follow up)
Suspected malaria cases, in
interval between two case
foreign people (Afghani &
Target regions Nationwide Households in the villages,
local malaria regions
Service centres Malaria labs,
health houses, hospitals
Health workers, mobile ma
Remark Active surveillance is usua
an interval of two weeks, u
transmission season, when
weekly. In areas with no m
on a monthly basis
Source of information: Raeisi et al. Determination of malaria epidemiolog
mentation of malaria elimination program in Iran.threatened, and tourism and cultural-scientiﬁc and commercial
exchange will be restricted in addition to the consequences of
the disease burden. Hence, it is essential for policy makers to
focus all of their efforts on malaria elimination. Understanding
the aspects of the disease throughout the country is important for
the national control of malaria [13]. This study aimed to evaluate
the status of malaria and determine the various epidemiological
aspects of the disease in Iran.
2. Materials and methods
This epidemiological study examined the status of malaria in
Iran from 2011 to 2014. In this study, the data were collected from
the Ministry of Health's protocol for controlling and eliminating
malaria, which is currently in use. To ﬁnd patients, we initially
collected blood samples from people with suspected malaria. The
samples were collected from health houses, urban and rural
community health centres, public and private hospitals, and patio
tables. In the patio table method, blood samples are collected by
health professionals from people who have a fever or prior history
of malaria to discover parasite carriers. Sampling was performed
by health centre workers and disease control experts.
The samples were sent to laboratories under the supervision of
the city health centres. The results of the sample analysis (active
or passive) were submitted online to the center for communicable
disease control in the Ministry of Health and Medical Education
on a daily basis, within 12 h from sampling. The results of the
analysis for active cases as well as the full details of the patients
were reported monthly to the center for communicable disease
control in the Ministry of Health by the unit ﬁghting against
diseases at the city health centre. The variables in this study
included sex, age, place of residence, nationality, occupation,
province, city, month, epidemiologic classiﬁcation of cases, the
parasite life stages, type of care, type of parasite, disease symp-
toms, travel history to contaminated areas, history of malaria for
the past 12 months, history of malaria for the past 12 months,
history of blood transfusion, intensity of malaria, treatment
outcome, type of service, and result of the disease.
In this research, the data of intervention programs of CDC
Iran's ministry of health and medical education has been used.
All the ethics have been applied.
Malaria surveillance was conducted using two main methods:
passive or active case ﬁnding (Table 1).g.
Active surveillance (Active foci)
fected people in the
ﬁnding activities,
Pakistani)
Persons who feel ill, were infected in the last
month, with history of malaria, from other
countries (Afghani & Pakistani)
mobile villagers in Active foci (in urban areas and villages that
have >50 households, around the reported
cases; in villages with <50 households, the
entire village)
laria team Health workers, mobile malaria team
lly conducted with
nless during
it is conducted
alaria transmission,
First active case detection is within 24 h of case
detection and continued for four consequent
weeks
ical status in Iran's malarious areas as baseline information for imple-
Figure 2. Distribution of the frequency of imported malaria cases, by age
group.
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The incidence rates decreased from 2011 to 2014. There were
4.76, 2.12, 1.80, and 1.59 per 100000 people, respectively from
2011 to 2014 (Figure 1).
During the four-year period (2011–2014), the highest
numbers of cases occurred in those aged 16–25 years, by age,
and in men, by sex (Figure 2).
Malaria was most common in men, with only 18.5% of
cases occurring in women over the four-year study. Most of the
cases occurred in rural areas and among workers. During the
four-year study, an average 52.58% of cases were Iranian. The
sampling method during the four-year period for the majority
of cases (49.5%) was the urban health centres' sampling unit,
followed by rural health centres (35.8%) and patio table (7.6%).
In addition, 0.4% of the cases had received blood in the past.
Complicated and severe malaria was present in 5.6% of the
cases. The treatment was successful in 83.2% of the cases.
Outpatient services were used by 79.1%, and only 4.8% of
patients were admitted to hospitals for treatment services. In
addition, 83.8% of patients recovered, and 0.1% of cases died
(Table 2).
During the four years of 2011–2014, 6542 cases of malaria
were mainly found in the provinces of Sistan and Baluchestan
and Hormozgan, and the highest incidence rates from 2011 toFigure 1. Malaria cases (per 100000) by Iran's provinces.2014 were located in Sistan and Baluchestan province. There
were 89.94, 43.9, 38.3, and 30.66 per 100000 people (Table 3).
This four-year study showed that the highest numbers of
malaria cases were recorded in the cities Sarbaz, Nickshahr, and
Chabahar in Sistan and Baluchestan province, and Bandar
Abbas, Bandar Jask, and Bandar Lengeh in Hormozgan prov-
ince (Table 3).
The number of malaria cases by month is reported in
Figure 3.
Table 2
Distribution of the frequency of reported cases based on the study variables [n(%)].
Variables Category 2011 2012 2013 2014
Sex Male 2810 (78.5) 1336 (82.4) 1128 (81.2) 1041 (83.7)
Female 762 (21.3) 285 (17.6) 262 (18.8) 202 (16.3)
Residence Urban 1254 (35.0) 553 (43.1) 385 (27.7) 434 (34.9)
Rural 2170 (60.6) 1046 (64.5) 921 (66.3) 712 (57.3)
Traveller 133 (3.7) 20 (1.2) 62 (4.5) 67 (5.4)
Nomadic 15 (0.7) 2 (0.1) 4 (0.3) 11 (0.9)
Nationality Iranian 1790 (50.0) 871 (53.7) 770 (55.4) 637 (51.2)
Pakistani 1068 (29.8) 476 (29.4) 437 (31.4) 330 (26.5)
Afghani 687 (19.2) 263 (16.2) 172 (12.4) 265 (21.3)
Other 27 (0.8) 11 (0.7) 11 (0.8) 11 (0.9)
Occupation Labourer 1565 (43.7) 695 (42.9) 462 (33.2) 508 (40.9)
Housewife 455 (12.7) 178 (11.0) 165 (11.9) 125 (10.1)
Student 331 (9.2) 167 (10.3) 92 (6.6) 90 (7.2)
Farmer 189 (5.3) 52 (3.2) 86 (6.2) 48 (3.9)
Driver 97 (2.7) 121 (7.5) 123 (8.8) 143 (11.5)
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5 categories: imported from abroad, indigenous, domestic
transmission relapsed and introduced. During the four years,
57.05% of the cases were imported from abroad.Table 3
Number of malaria cases in Iran, by city [n (%)].
Province City 2011
Sistan & Baluchestan Sarbaz 848 (23.7
Chabahar 819 (22.9
Nikshahr 252 (7.0
Saravan 225 (6.3
Iranshahr 112 (3.1
Konarak 109 (3.0
Zahedan 52 (1.5
Khash 11 (0.3
Sibosooran
Zabol
Hormozgan Bandar Abbas 183 (5.1
Bandar Jask 150 (4.2
Bandar Lengeh 96 (2.7
Rudan 26 (0.7
Qeshm
Minab 18 (0.5
Sirik 12 (0.3
Bashagard 11 (0.3
Booshehr Booshehr 33 (0.9
Kangan 14 (0.4
Dashtestan
Qom Qom 168 (4.7
Fars Shiraz 102 (2.8
Jahrom 14 (0.4
Larestan 11 (0.3
Tehran Tehran 24 (0.7
Rey 14 (0.4
Shemiranat
Varamin
Isfahan Isfahan 21 (0.6
Kerman Roodbar Jonoob 15 (0.4
Kerman
Rafsanjan
Yazd Yazd 12 (0.3
Alborz Karaj
Khorasan Razavi Mashhad
Khoozestan Dashte AzadeganThe trophozoite lifecycle was present in most cases. Sur-
veillance in the majority of cases was inactive care. This in-
dicates that there were diagnostic and treatment facilities
available for a high-risk population that allowed patients to2012 2013 2014
) 394 (24.3) 390 (28.1) 313 (25.2)
) 305 (18.8) 187 (13.5) 193 (15.5)
) 90 (5.6) 25 (1.8) 18 (1.4)
) 238 (14.7) 329 (23.7) 158 (12.7)
) 71 (4.4) 42 (3.0) 36 (2.9)
) 60 (3.7) 55 (4.0) 37 (3.0)
) 6 (2.2) 45 (3.2) 18 (1.4)
) 14 (0.9) 13 (0.9) 4 (0.3)
41 (3.3)
67 (5.4)
) 38 (2.3) 20 (1.4) 13 (1.0)
) 37 (2.3) 12 (0.9) 15 (1.2)
) 24 (1.5) 18 (1.3) 14 (1.1)
) 4 (0.3) 6 (0.5)
20 (1.2) 14 (1.0) 18 (1.4)
) 11 (0.7) 21 (1.5) 6 (0.5)
)
) 6 (0.4)
) 45 (2.8) 9 (0.6) 52 (4.2)
) 12 (0.7) 7 (0.5) 10 (0.8)
5 (0.4)
) 11 (0.7) 37 (2.7) 15 (1.2)
) 35 (2.2) 18 (1.3) 34 (2.7)
) 11 (0.7) 5 (0.4) 5 (0.4)
) 5 (0.3) 4 (0.3)
) 18 (1.1) 22 (1.6) 37 (0.3)
)
4 (0.3) 10 (0.8)
5 (0.3)
) 12 (0.7) 10 (0.7) 16 (1.3)
)
5 (0.4) 4 (0.3)
7 (0.6)
) 13 (0.8) 7 (0.5) 4 (0.3)
10 (0.6)
5 (1.1) 8 (0.6)
4 (0.3)
05
10
15
20
25
 Year 2011
Year 2012
Year 2013
Year 2014
Figure 3. Distribution of the frequency of imported malaria cases in Iran,
by month.
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nostic tests.
The medication used most frequently for treatment was
artesunate, in both oral and injectable forms. The majority of
patients reported a history of travelling to Pakistan. The most
frequently occurring danger signs of malaria during 2011–2014
were anaemia, hypotension, and hypoglycaemia. Regarding a
history of travelling to malaria-infected areas, 43.6% of patients
travelled to Pakistan and 10.2% to Afghanistan (Table 4).Table 4
Malaria information in Iran, 2011–2014.
Variables Category
Epidemiological classiﬁcation of cases Imported from abroad
Indigenous
Domestically transmitted
Relapse
Introduced
Lifecycle of the malaria parasite Gametocytes + trophozoite
Trophozoite
Schizont
Gametocytes
Surveillance Passive
Routine
Active foci
Parasite species Plasmodium vivax
Mixed (vivax and falciparum)
Plasmodium falciparum
Malariae
Type of treatment Oral artesunate
Injectable artesunate
Oral quinine
Injectable quinine
Coartem
Danger signs of malaria Anaemia
Hypotension
Hypoglycaemia
Respiratory failure
Bleeding
Dark urine
Convulsions
Jaundice
Disturbance of consciousness
Gait abnormalities
History of travelling to infected areas Pakistan
Afghanistan
Other malaria-prone countries
Inside Iran
None4. Discussion
The results of the present study showed that the incidence
rates decreased from 2011 to 2014. Results of other studies also
indicate a declining trend in the incidence rate of malaria in Iran
[14,15]. The National Malaria Control Program reported a
reduction in malaria cases, from an annual average of 16786
cases during 2001–2006 to 6122 cases in 2009 (64% decline),
with 100% conﬁrmation. The main reason might be the
changing environmental conditions, i.e., drought, for anopheles
breeding and survival. Integration of vector management using
long-lasting insecticide-treated bed nets, active case detection
and treatment through the implementation of mobile teams, and
increased ﬁnancial resources for the malaria control program
might also have contributed.
According to Fekri et al., improving the awareness, attitudes,
and performance of people also helps to reduce the number of
malaria cases. Although Iran is in the pre-elimination stage of
malaria, the increase in locally transmitted cases and develop-
ment of active centres of the disease are concerning. Further-
more, the higher burden in Fars and Isfahan provinces than in
Kerman province is a serious warning for Iranian health ofﬁ-
cials. To eliminate the disease and prevent its return, we need to
increase the knowledge of people regarding the control and
treatment of malaria. Also, there should be health education2011 2012 2013 2014
1717 (48.0) 825 (50.9) 835 (60.1) 860 (69.2)
1270 (35.5) 523 (32.3) 366 (26.3) 243 (19.5)
426 (11.9) 224 (13.8) 137 (9.9) 100 (8.0)
54 (1.5) 18 (1.1) 15 (1.1) 22 (1.8)
105 (2.9) 31 (1.9) 26 (1.9) 11 (0.9)
755 (21.1) 312 (19.2) 284 (20.4) 331 (26.6)
2314 (64.7) 1037 (64.0) 857 (61.7) 687 (55.3)
189 (5.3) 105 (6.5) 67 (4.8) 78 (6.3)
314 (8.8) 167 (10.3) 147 (10.6) 122 (9.8)
2113 (59.0) 937 (57.8) 849 (61.1) 717 (57.7)
1236 (34.5) 625 (38.6) 493 (35.5) 497 (40.0)
223 (6.2) 59 (3.6) 46 (3.3) 28 (2.3)
3013 (84.2) 1410 (87.0) 1079 (77.6) 1104 (88.8)
109 (3.0) 66 (4.1) 59 (4.2) 23 (1.9)
449 (12.5) 144 (8.9) 238 (17.1) 111 (8.9)
1 (0.0) 1 (0.1) 1 (0.1) 1 (0.1)
15 (0.9) 26 (1.9) 17 (1.4)
15 (0.9) 22 (1.6) 19 (1.5)
2 (0.1) 7 (0.5) 6 (0.5)
5 (0.3) 1 (0.1)
7 (0.4)
10 (0.6) 9 (0.6) 12 (1.0)
10 (0.6) 15 (1.1) 10 (0.8)
18 (1.3) 7 (0.6)
3 (0.2) 11 (0.8) 7 (0.6)
1 (0.1) 5 (0.4) 1 (0.1)
8 (0.5) 5 (0.4) 4 (0.3)
5 (0.3) 4 (0.3)
9 (0.6) 10 (0.7) 1 (0.1)
5 (0.3) 13 (0.9) 7 (0.6)
9 (0.6) 12 (0.9) 5 (0.4)
1341 (37.5) 671 (41.4) 612 (44.0) 640 (51.5)
412 (11.5) 150 (9.3) 97 (7.0) 162 (13.0)
37 (1.0) 17 (1.0) 22 (1.6) 25 (2.0)
255 (7.1) 142 (8.8) 95 (6.8) 117 (9.4)
1527 (42.7) 641 (39.5) 524 (37.7) 287 (23.1)
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personal protection and environmental improvement to prevent
the creation of new centres in border regions.
Unfortunately, neighbouring countries such as Afghanistan,
Pakistan, Iraq, and some former Soviet republics have created
challenges for the control of malaria in Iran [16]. It is also
necessary for Iranian health ofﬁcials to better control the
borders and prevent irregular migration to Iran to cut off the
chain of disease transmission and eliminate the disease [17,18].
Through the Malaria Case Notiﬁcation System (MCNS), all of
the cases of malaria have to be reported by all health care
units and medical units of medical universities to the disease
control and elimination of malaria ofﬁce. Thus, detection and
reporting of all diagnosed cases of malaria are possible in the
shortest possible time, and the elimination of malaria will
progress more quickly and accurately.
The highest number of cases occurred in those aged 16–25
years. The increase in malaria in people older than 16 years
might be due to the increase in the number of immigrants from
Pakistan and Afghanistan who are looking for jobs. However,
the disease tended to decline in people <4 years old or >15
years old during 2002–2007 [12,19]. The highest incidence of
the disease was present in men, which is justiﬁed by the
increase in the number of immigrants from Pakistan and
Afghanistan. However, the number of male patients
decreased from 2002 to 2007 by approximately 12%. Sex
does not naturally or directly inﬂuence the sensitivity or
resistance to malaria, but it is possible that the effects are via
occupation or coverage. Social activities and the presence of
men outside the home increase their susceptibility to
mosquito bites. The high number of workers suggests the
importance of health literacy and training in this group by
health care providers through avenues such as mass media
[11]. The disease process in terms of location was primarily
in villages during 2011–2014. This ﬁnding is consistent with
the results of other studies.
Therefore, we can conclude that malaria is a local issue in
Iran. Because the migrant workforce is concentrated in cities and
their borders, there were more malaria cases observed in cities
than in the past [13]. In terms of nationality, the highest numbers
of cases were in Iranian, Pakistani, and Afghani people.
Annually, 3000–8000 cases of malaria come to Iran from
neighbouring countries. From 2010 to 2011, most of the cases
were non-Iranian (Pakistani, Afghani, and other nationalities).
This reﬂects the intensiﬁcation of control measures in recent
years. However, in this study, an average 47.42% of patients
were Pakistani or Afghani. Therefore, it is necessary to routinely
conduct blood tests for Afghani and Pakistani citizens in patio
care, especially at the beginning of transmission season. Because
of the relative safety, these people might be asymptomatic;
however, the parasite might be present in the blood. Interest-
ingly, the present results showed that an average 26.9% of pa-
tients had a history of travelling to Pakistan or Afghanistan.
Therefore, people with a history of travelling to malaria-infected
areas should also be examined for the disease.
Most of the cases were detected in Sistan and Baluchestan
and Hormozgan provinces. These provinces were the focus of
malaria and are at risk of the return of malaria owing to the
presence of predisposing factors for malaria transmission such as
high population exchange with malaria-prone regions (Pakistan
and Afghanistan), infectious reservoirs, favourable weather
conditions (temperatures >16 C and humidity >50%), highfrequency of transmission, and large number of carriers. A
malaria elimination program needs to focus not only on inter-
rupting the local transmission but also on trying to prevent and
control imported disease and the chain of its transmission to
local residents. Policy makers should try to reduce the number of
new autochthonous malaria cases to zero and make the high-risk
areas clear regions (annual parasite index = 01) [13].
The number of cases in the provinces of Fars and Isfahan was
higher than in Kerman province. However, regarding the prev-
alence of the disease by province, Kerman province has been
ranked ﬁrst or third [20]. Hence, determining the disease
prevalence and consideration of the disease control program in
all provinces of Iran is of high importance. Most cases were
detected in the cities of Sarbaz, Chabahar, and Nikshahr in
Sistan and Baluchestan province. Yousseﬁ & Rahimi (2011)
reported that there were 1464 malaria cases in the city of
Sarbaz between 2009 and 2010. In the study by Sargolzaie
et al. (2008), the highest numbers of cases were detected in
Chabahar (31%), Sarbaz (24.3%), and Nikshahr (10.2)
between 2008 and 2011. These rates might be related with
favourable environmental conditions, including a long hot
season and stagnant water, in addition to the quality of the
malaria surveillance system in the cities and travel to the
eastern borders [21].
Most cases were recorded during September and August.
However, in 2012, most cases were reported during May and
June. The highest incidence of the disease in previous studies
was in summer [22]. The increase in imported cases and local
transmission in addition to the decrease in domestically
transmitted cases show that the number of autochthonous
malaria cases is currently decreasing in Iran and that the
necessity of controlling the country borders is increasingly
becoming important [13]. Vivax malaria accounted for the
highest rates of malaria, as in 2002 and 2007 [13], and, other
than 2013, there was an increasing trend. Therefore, the
falciparum infection rate is declining and being replaced by
the same number of cases of vivax. This might be due to the
reduced number of Afghan and Pakistani refugees and
improved diagnostic and treatment services. Severe and
complicated malaria was present in 5.6% of patients. This can
lead to treatment failure and the need for inpatient services.
Prompt disease treatment and parasite elimination from the
body can prevent the disease. It also prevents uncomplicated
malaria from becoming complicated and severe malaria and
also disease transmission in the community.
Despite the recent declining trend in reported cases, the
expansion of local transmission, especially in areas affected by
border travelling, is concerning. Unfortunately, neighbouring
countries such as Afghanistan and Pakistan have created chal-
lenges in controlling malaria in Iran.
To meet the ultimate goal of malaria elimination by 2025,
steps should include the interruption of the local transmission of
malaria; improvements in malaria control interventions,
including programs to control border travel and focused in-
terventions for high incidence areas and high-risk groups such as
rural residents, men, workers, and people younger than 35 years;
and interventions based on the environmental life cycle of the
mosquito anopheles and the peak incidence time in the province.
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